Literature DB >> 15461605

Is secondary lymphoid-organ chemokine (SLC/CCL21) much more than a constitutive chemokine?

H M Serra1, C E Baena-Cagnani, Y Eberhard.   

Abstract

Chemokines are a superfamily of small cytokines with activities ranging from leukocyte traffick to hematopoiesis, angiogenesis, and tissue organogenesis. Secondary lymphoid-organ chemokine (SLC/CCL21) was originally reported as a chemokine constitutively expressed by stromal cells and high endothelial venules in secondary lymphoid tissues and endothelium of afferent lymphatics, directing CCR7+ cells. More recently, others and we have demonstrated that SLC/CCL21 is up-regulated in different skin inflammatory conditions. Thereafter, this molecule is much more than a constitutive chemokine, which could play a role in effector and regulatory immune functions. Copyright 2004 Blackwell Munksgaard

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15461605     DOI: 10.1111/j.1398-9995.2004.00531.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  6 in total

Review 1.  Chemokines in inflammatory bowel disease.

Authors:  S Danese; A Gasbarrini
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

Review 2.  Clinically feasible approaches to potentiating cancer cell-based immunotherapies.

Authors:  V I Seledtsov; A G Goncharov; G V Seledtsova
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 3.  In situ tissue regeneration: chemoattractants for endogenous stem cell recruitment.

Authors:  Wendy S Vanden Berg-Foels
Journal:  Tissue Eng Part B Rev       Date:  2013-07-11       Impact factor: 6.389

4.  Convolution of chemoattractant secretion rate, source density, and receptor desensitization direct diverse migration patterns in leukocytes.

Authors:  Yana Wang; Darrell J Irvine
Journal:  Integr Biol (Camb)       Date:  2013-03       Impact factor: 2.192

5.  Up-regulation of the chemokine CCL21 in the skin of subjects exposed to irritants.

Authors:  Yanina Eberhard; Susana Ortiz; Alejandro Ruiz Lascano; Raquel Kuznitzky; Horacio Marcelo Serra
Journal:  BMC Immunol       Date:  2004-04-26       Impact factor: 3.615

6.  Chemokines as Cancer Vaccine Adjuvants.

Authors:  Iuliana D Bobanga; Agne Petrosiute; Alex Y Huang
Journal:  Vaccines (Basel)       Date:  2013-12-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.